Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $1,241 - $2,430
30 Added 176.47%
47 $2,000
Q1 2021

May 11, 2021

SELL
$101.51 - $125.27 $304 - $375
-3 Reduced 15.0%
17 $2,000
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $1,454 - $1,850
20 New
20 $2,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Aua Capital Management, LLC Portfolio

Follow Aua Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aua Capital Management, LLC with notifications on news.